Business Description
Shenzhen YHLO Biotech Co Ltd
ISIN : CNE100005204
Share Class Description:
SHSE:688575: Class ACompare
Compare
Traded in other countries / regions
688575.China IPO Date
2021-05-17Description
Shenzhen YHLO Biotech Co Ltd is an innovative enterprise focusing on overall clinical laboratory solutions with leading domestic technology and integrated research, production and marketing. Its main business is research and development, production and sales of in vitro diagnostic instruments and supporting reagents based on chemiluminescence immunoassay.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.56 | |||||
| Equity-to-Asset | 0.65 | |||||
| Debt-to-Equity | 0.32 | |||||
| Debt-to-EBITDA | 2.94 | |||||
| Interest Coverage | 30.36 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 5.47 | |||||
| Beneish M-Score | -3.24 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 22.2 | |||||
| 3-Year EBITDA Growth Rate | 13.7 | |||||
| 3-Year EPS without NRI Growth Rate | -3.9 | |||||
| 3-Year Book Growth Rate | 44.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 46.63 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 18.51 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.73 | |||||
| 9-Day RSI | 38.09 | |||||
| 14-Day RSI | 39.89 | |||||
| 3-1 Month Momentum % | -10.2 | |||||
| 6-1 Month Momentum % | -23.9 | |||||
| 12-1 Month Momentum % | -19.68 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.03 | |||||
| Quick Ratio | 1.28 | |||||
| Cash Ratio | 0.53 | |||||
| Days Inventory | 349.05 | |||||
| Days Sales Outstanding | 80.1 | |||||
| Days Payable | 124.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.57 | |||||
| Dividend Payout Ratio | 0.49 | |||||
| Forward Dividend Yield % | 1.57 | |||||
| 5-Year Yield-on-Cost % | 1.54 | |||||
| 3-Year Average Share Buyback Ratio | -3.7 | |||||
| Shareholder Yield % | 0.41 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 64.64 | |||||
| Operating Margin % | 18.11 | |||||
| Net Margin % | 15.18 | |||||
| FCF Margin % | 3.47 | |||||
| ROE % | 11.17 | |||||
| ROA % | 7.38 | |||||
| ROIC % | 9.85 | |||||
| 3-Year ROIIC % | 1.38 | |||||
| ROC (Joel Greenblatt) % | 13.84 | |||||
| ROCE % | 9.46 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 34.9 | |||||
| Forward PE Ratio | 17.43 | |||||
| PE Ratio without NRI | 31.11 | |||||
| PEG Ratio | 0.62 | |||||
| PS Ratio | 5.3 | |||||
| PB Ratio | 3.75 | |||||
| Price-to-Tangible-Book | 4.04 | |||||
| Price-to-Free-Cash-Flow | 154.42 | |||||
| Price-to-Operating-Cash-Flow | 13.72 | |||||
| EV-to-EBIT | 36.55 | |||||
| EV-to-EBITDA | 36.55 | |||||
| EV-to-Revenue | 5.53 | |||||
| EV-to-FCF | 159.02 | |||||
| Price-to-GF-Value | 0.95 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.78 | |||||
| Price-to-Graham-Number | 2.36 | |||||
| Price-to-Net-Current-Asset-Value | 26.77 | |||||
| Earnings Yield (Greenblatt) % | 2.74 | |||||
| FCF Yield % | 0.67 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shenzhen YHLO Biotech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,902.02 | ||
| EPS (TTM) (Â¥) | 0.5 | ||
| Beta | 1.34 | ||
| 3-Year Sharpe Ratio | -0.06 | ||
| 3-Year Sortino Ratio | -0.09 | ||
| Volatility % | 44.4 | ||
| 14-Day RSI | 39.89 | ||
| 14-Day ATR (Â¥) | 0.494453 | ||
| 20-Day SMA (Â¥) | 17.723 | ||
| 12-1 Month Momentum % | -19.68 | ||
| 52-Week Range (Â¥) | 16.82 - 28.27 | ||
| Shares Outstanding (Mil) | 570.27 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shenzhen YHLO Biotech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shenzhen YHLO Biotech Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shenzhen YHLO Biotech Co Ltd Frequently Asked Questions
What is Shenzhen YHLO Biotech Co Ltd(SHSE:688575)'s stock price today?
The current price of SHSE:688575 is ¥17.40. The 52 week high of SHSE:688575 is ¥28.27 and 52 week low is ¥16.82.
When is next earnings date of Shenzhen YHLO Biotech Co Ltd(SHSE:688575)?
The next earnings date of Shenzhen YHLO Biotech Co Ltd(SHSE:688575) is .
Does Shenzhen YHLO Biotech Co Ltd(SHSE:688575) pay dividends? If so, how much?
The Dividend Yield %  of Shenzhen YHLO Biotech Co Ltd(SHSE:688575) is 1.57% (As of Today), Highest Dividend Payout Ratio of Shenzhen YHLO Biotech Co Ltd(SHSE:688575) was 1.15. The lowest was 0.24. And the median was 0.7. The  Forward Dividend Yield % of Shenzhen YHLO Biotech Co Ltd(SHSE:688575) is 1.57%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers